79 related articles for article (PubMed ID: 11810949)
1. Garlic reduces saquinavir blood levels 50%; may affect other drugs.
James JS
AIDS Treat News; 2001 Dec; (375):2-3. PubMed ID: 11810949
[No Abstract] [Full Text] [Related]
2. Garlic supplements found to lower saquinavir levels.
TreatmentUpdate; 2001; 12(12):17-8. PubMed ID: 11570085
[No Abstract] [Full Text] [Related]
3. Garlic supplements can impede HIV medication.
J Am Coll Surg; 2002 Feb; 194(2):251. PubMed ID: 11848645
[No Abstract] [Full Text] [Related]
4. The effect of garlic supplements on the pharmacokinetics of saquinavir.
Piscitelli SC; Burstein AH; Welden N; Gallicano KD; Falloon J
Clin Infect Dis; 2002 Jan; 34(2):234-8. PubMed ID: 11740713
[TBL] [Abstract][Full Text] [Related]
5. Garlic supplements can impede HIV medication.
Sussman E
AIDS; 2002 Jun; 16(9):N5. PubMed ID: 12090243
[No Abstract] [Full Text] [Related]
6. NIH studies link between saquinavir and garlic pills.
AIDS Alert; 2002 Feb; 17(2):26. PubMed ID: 11862747
[No Abstract] [Full Text] [Related]
7. Garlic supplements and saquinavir.
Borek C
Clin Infect Dis; 2002 Aug; 35(3):343. PubMed ID: 12115105
[No Abstract] [Full Text] [Related]
8. Co-trimoxazole administered for Pneumocystis carinii pneumonia prophylaxis does not interfere with saquinavir pharmacokinetics.
Maserati R; Villani P; Cocchi L; Regazzi MB
AIDS; 1998 May; 12(7):815-6. PubMed ID: 9619815
[No Abstract] [Full Text] [Related]
9. Garlic supplements and HIV medication.
Am Fam Physician; 2002 Mar; 65(6):1225. PubMed ID: 11925097
[No Abstract] [Full Text] [Related]
10. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
Kakuda TN; Falcon RW
Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic characterization of a human immunodeficiency virus protease inhibitor, saquinavir, during ethanol intake in rats.
Shibata N; Kageyama M; Kishida T; Kimura K; Yoshikawa Y; Kuwahara T; Toh J; Shirasaka T; Takada K
Biopharm Drug Dispos; 2003 Nov; 24(8):335-44. PubMed ID: 14595702
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic monitoring of HIV-1 protease inhibitors in the antiretroviral therapy.
Pawiński T; Pulik P; Gralak B; Horban A
Acta Pol Pharm; 2008; 65(1):93-100. PubMed ID: 18536180
[TBL] [Abstract][Full Text] [Related]
13. Diurnal variation of plasma protease inhibitor concentrations.
Justesen US; Pedersen C
AIDS; 2002 Dec; 16(18):2487-9. PubMed ID: 12461428
[No Abstract] [Full Text] [Related]
14. Development of a chromatographic method for the determination of saquinavir in plasma samples of HIV patients.
Campanero MA; Escolar M; Arangoa MA; Sádaba B; Azanza JR
Biomed Chromatogr; 2002 Feb; 16(1):7-12. PubMed ID: 11816005
[TBL] [Abstract][Full Text] [Related]
15. Transwell-grown HepG2 cell monolayers as in vitro permeability model to study drug-drug or drug-food interactions.
Berginc K; Kristl A
J Med Food; 2011; 14(1-2):135-9. PubMed ID: 21138349
[TBL] [Abstract][Full Text] [Related]
16. Limited-sampling strategy for the prediction of boosted hard-gel saquinavir exposure at a dosage of 1000/100 mg twice daily in human immunodeficiency virus-infected individuals.
Dickinson L; Back D; Pozniak A; Khoo S; Boffito M
Ther Drug Monit; 2007 Jun; 29(3):361-7. PubMed ID: 17529895
[TBL] [Abstract][Full Text] [Related]
17. Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software.
Lavielle M; Mentré F
J Pharmacokinet Pharmacodyn; 2007 Apr; 34(2):229-49. PubMed ID: 17211713
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
[TBL] [Abstract][Full Text] [Related]
19. The influence of aged garlic extract on the uptake of saquinavir and darunavir into HepG2 cells and rat liver slices.
Berginc K; Trontelj J; Kristl A
Drug Metab Pharmacokinet; 2010; 25(3):307-13. PubMed ID: 20610890
[TBL] [Abstract][Full Text] [Related]
20. Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg.
Ananworanich J; Siangphoe U; Mahanontharit A; Hill A; Hirschel B; Ruxrungtham K
Antivir Ther; 2004 Dec; 9(6):1035-6. PubMed ID: 15651763
[No Abstract] [Full Text] [Related]
[Next] [New Search]
